Long QT Syndrome News and Research

RSS
Long QT syndrome (LQTS) is a disease that affects the normal heart rhythm and electrical activity. It may lead to sudden onset and dangerous arrhythmias (irregularities of heart rate and rhythm) which may be brought on by triggers like exercise or stress.
Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Study shows VATS-LCSD can help children with refractory cardiac arrhythmias

Study shows VATS-LCSD can help children with refractory cardiac arrhythmias

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Researchers discover genetic variants of heart disorder in some cases of stillbirth

Researchers discover genetic variants of heart disorder in some cases of stillbirth

Investigators discover two new genes associated with severe early-onset disorders of heart rhythm

Investigators discover two new genes associated with severe early-onset disorders of heart rhythm

Researchers find new genetic differences in human hearts

Researchers find new genetic differences in human hearts

Bayer, Onyx announce data from Nexavar Phase 3 trial on RAI-refractory differentiated thyroid cancer

Bayer, Onyx announce data from Nexavar Phase 3 trial on RAI-refractory differentiated thyroid cancer

Exercise clue to long QT syndrome prognosis

Exercise clue to long QT syndrome prognosis

Computer simulation can predict risk of irregular heart rhythms and sudden cardiac death

Computer simulation can predict risk of irregular heart rhythms and sudden cardiac death

NHCS researchers develop human heart cell model of ARVC

NHCS researchers develop human heart cell model of ARVC

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Study confirms electrical storm as potent risk factor for death and impaired quality of life

Study confirms electrical storm as potent risk factor for death and impaired quality of life

Cardiovascular screening with ECG in young athletes is cost effective

Cardiovascular screening with ECG in young athletes is cost effective

New drug may be useful in treating long QT syndrome

New drug may be useful in treating long QT syndrome

New drug shows promise for Long QT syndrome

New drug shows promise for Long QT syndrome

Congenital long QT syndrome guidelines ‘too restrictive’

Congenital long QT syndrome guidelines ‘too restrictive’

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC